Real-world evidence of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) in the United States (US). Jacobson, C. A., Locke, F., Hu, Z., Siddiqi, T., Ahmed, S., Ghobadi, A., Miklos, D., Lin, Y., Perales, M., Lunning, M., Herr, M., Hill, B. T., Ganguly, S., Dong, H., Nikiforow, S., Xie, J., Xu, H., Hooper, M., Kawashima, J., Pasquini, M. C. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.7552

View details for Web of Science ID 000708120604149